KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Accured Expenses (2016 - 2025)

Teladoc Health's Change in Accured Expenses history spans 12 years, with the latest figure at $18.1 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 17.14% year-over-year to $18.1 million; the TTM value through Dec 2025 reached $13.3 million, up 164.86%, while the annual FY2025 figure was $13.3 million, 164.86% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $18.1 million at Teladoc Health, up from $4.8 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $19.7 million in Q4 2022 and bottomed at -$52.0 million in Q1 2024.
  • The 5-year median for Change in Accured Expenses is $10.2 million (2022), against an average of -$249400.0.
  • The largest annual shift saw Change in Accured Expenses crashed 216.16% in 2021 before it surged 153.41% in 2023.
  • A 5-year view of Change in Accured Expenses shows it stood at $12.7 million in 2021, then surged by 55.7% to $19.7 million in 2022, then decreased by 5.02% to $18.7 million in 2023, then dropped by 17.62% to $15.4 million in 2024, then grew by 17.14% to $18.1 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Change in Accured Expenses are $18.1 million (Q4 2025), $4.8 million (Q3 2025), and $11.9 million (Q2 2025).